
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (30): 3740-3747.DOI: 10.12114/j.issn.1007-9572.2023.0168
Special Issue: 睡眠研究最新文章合辑; 睡眠问题专题研究
• Original Research • Previous Articles Next Articles
Received:2023-02-11
Revised:2023-05-26
Published:2023-10-20
Online:2023-05-26
Contact:
ZHANG Xiangyang
通讯作者:
张向阳
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0168
| 组别 | 例数 | 年龄(岁) | 性别〔例(%)〕 | 吸烟〔例(%)〕 | 饮酒〔例(%)〕 | 身高(cm) | 体质量(kg) | BMI(kg/m2) | 颈围(cm) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 女 | 男 | 无 | 有 | 无 | 有 | |||||||
| 非OSA组 | 657 | 44.9±11.0 | 307(46.7) | 350(53.3) | 412(62.7) | 245(37.3) | 425(64.7) | 232(35.3) | 168.35±8.05 | 79.58±13.94 | 28.0±4.1 | 39.56±3.77 |
| OSA组 | 2 193 | 49.7±10.8 | 685(31.2) | 1 508(68.8) | 1 306(59.6) | 887(40.4) | 1 357(61.9) | 836(38.1) | 169.28±7.97 | 80.45±13.43 | 28.0±3.8 | 40.03±3.85 |
| 检验统计量值 | -9.96b | 52.79a | 1.97a | 1.58a | 2.61b | -1.45b | 0.01b | -2.72b | ||||
| P值 | <0.001 | <0.001 | 0.160 | 0.208 | 0.009 | 0.146 | 0.994 | 0.006 | ||||
| 组别 | 腰围(cm) | 收缩压(mmHg) | 舒张压(mmHg) | TC〔M(P25,P75),mmol/L〕 | TG〔M(P25,P75),mmol/L〕 | HDL-C〔M(P25,P75),mmol/L〕 | LDL-C〔M(P25,P75),mmol/L〕 | AHI〔M(P25,P75),次/h〕 | 睡眠有效率〔M(P25,P75),%〕 | |||
| 非OSA组 | 99.14±10.79 | 140±20 | 91±14 | 4.43(3.76,4.96) | 1.42(1.05,2.01) | 1.12(0.94,1.32) | 2.59(2.00,3.08) | 1.7(0.7,3.1) | 70.9(61.7,79.4) | |||
| OSA组 | 99.60±10.65 | 134±19 | 92±14 | 4.47(3.87,5.10) | 1.76(1.28,2.48) | 1.06(0.90,1.25) | 2.59(2.11,3.12) | 18.7(10.3,33.8) | 71.2(61.7,79.3) | |||
| 检验统计量值 | -0.98b | 0.50b | -1.21b | -2.35c | -8.95c | -4.84c | -1.43c | -38.94c | -0.30c | |||
| P值 | 0.328 | 0.615 | 0.226 | 0.019 | <0.001 | <0.001 | 0.153 | <0.001 | 0.767 | |||
| 组别 | 总睡眠时间〔M(P25,P75),min〕 | 平均SaO2〔M(P25,P75),%〕 | 最低SaO2〔M(P25,P75),%〕 | CVAI〔M(P25,P75)〕 | AIP〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | LAP〔M(P25,P75)〕 | VAI〔M(P25,P75)〕 | ||||
| 非OSA组 | 376.0(324.0,419.0) | 94(93,95) | 88(87,90) | 111.05(86.07,138.83) | 0.13(-0.06,0.32) | 0.75(0.48,1.18) | 52.80(34.40,79.10) | 2.08(1.37,3.23) | ||||
| OSA组 | 373.5(325.5,415.5) | 92(91,94) | 80(75,84) | 145.09(119.88,171.53) | 0.22(0.04,0.41) | 1.00(0.64,1.55) | 64.35(42.90,98.70) | 2.64(1.74,4.06) | ||||
| 检验统计量值 | -0.73c | -21.70c | -34.29c | -17.77c | -7.24c | -9.01c | -7.32c | -8.37c | ||||
| P值 | 0.464 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Table 1 Comparison of clinical data between the two groups of patients
| 组别 | 例数 | 年龄(岁) | 性别〔例(%)〕 | 吸烟〔例(%)〕 | 饮酒〔例(%)〕 | 身高(cm) | 体质量(kg) | BMI(kg/m2) | 颈围(cm) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 女 | 男 | 无 | 有 | 无 | 有 | |||||||
| 非OSA组 | 657 | 44.9±11.0 | 307(46.7) | 350(53.3) | 412(62.7) | 245(37.3) | 425(64.7) | 232(35.3) | 168.35±8.05 | 79.58±13.94 | 28.0±4.1 | 39.56±3.77 |
| OSA组 | 2 193 | 49.7±10.8 | 685(31.2) | 1 508(68.8) | 1 306(59.6) | 887(40.4) | 1 357(61.9) | 836(38.1) | 169.28±7.97 | 80.45±13.43 | 28.0±3.8 | 40.03±3.85 |
| 检验统计量值 | -9.96b | 52.79a | 1.97a | 1.58a | 2.61b | -1.45b | 0.01b | -2.72b | ||||
| P值 | <0.001 | <0.001 | 0.160 | 0.208 | 0.009 | 0.146 | 0.994 | 0.006 | ||||
| 组别 | 腰围(cm) | 收缩压(mmHg) | 舒张压(mmHg) | TC〔M(P25,P75),mmol/L〕 | TG〔M(P25,P75),mmol/L〕 | HDL-C〔M(P25,P75),mmol/L〕 | LDL-C〔M(P25,P75),mmol/L〕 | AHI〔M(P25,P75),次/h〕 | 睡眠有效率〔M(P25,P75),%〕 | |||
| 非OSA组 | 99.14±10.79 | 140±20 | 91±14 | 4.43(3.76,4.96) | 1.42(1.05,2.01) | 1.12(0.94,1.32) | 2.59(2.00,3.08) | 1.7(0.7,3.1) | 70.9(61.7,79.4) | |||
| OSA组 | 99.60±10.65 | 134±19 | 92±14 | 4.47(3.87,5.10) | 1.76(1.28,2.48) | 1.06(0.90,1.25) | 2.59(2.11,3.12) | 18.7(10.3,33.8) | 71.2(61.7,79.3) | |||
| 检验统计量值 | -0.98b | 0.50b | -1.21b | -2.35c | -8.95c | -4.84c | -1.43c | -38.94c | -0.30c | |||
| P值 | 0.328 | 0.615 | 0.226 | 0.019 | <0.001 | <0.001 | 0.153 | <0.001 | 0.767 | |||
| 组别 | 总睡眠时间〔M(P25,P75),min〕 | 平均SaO2〔M(P25,P75),%〕 | 最低SaO2〔M(P25,P75),%〕 | CVAI〔M(P25,P75)〕 | AIP〔M(P25,P75)〕 | CMI〔M(P25,P75)〕 | LAP〔M(P25,P75)〕 | VAI〔M(P25,P75)〕 | ||||
| 非OSA组 | 376.0(324.0,419.0) | 94(93,95) | 88(87,90) | 111.05(86.07,138.83) | 0.13(-0.06,0.32) | 0.75(0.48,1.18) | 52.80(34.40,79.10) | 2.08(1.37,3.23) | ||||
| OSA组 | 373.5(325.5,415.5) | 92(91,94) | 80(75,84) | 145.09(119.88,171.53) | 0.22(0.04,0.41) | 1.00(0.64,1.55) | 64.35(42.90,98.70) | 2.64(1.74,4.06) | ||||
| 检验统计量值 | -0.73c | -21.70c | -34.29c | -17.77c | -7.24c | -9.01c | -7.32c | -8.37c | ||||
| P值 | 0.464 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||
| 变量 | 区间 | B | SE | Wald χ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|---|
| AIP | Q1(<0.01) | 50.356 | |||||
| Q2(0.01~0.20) | 0.337 | 0.119 | 8.071 | 1.401 | (1.110,1.767) | 0.004 | |
| Q3(0.21~0.39) | 0.639 | 0.124 | 26.469 | 1.896 | (1.486,2.418) | <0.001 | |
| Q4(>0.39) | 0.838 | 0.129 | 42.075 | 2.311 | (1.794,2.976) | <0.001 | |
| VAI | Q1(<1.64) | 63.619 | |||||
| Q2(1.64~2.49) | 0.432 | 0.118 | 13.281 | 1.540 | (1.221,1.942) | <0.001 | |
| Q3(2.50~3.86) | 0.713 | 0.124 | 33.100 | 2.040 | (1.600,2.600) | <0.001 | |
| Q4(>3.86) | 0.954 | 0.130 | 53.855 | 2.595 | (2.012,3.348) | <0.001 | |
| LAP | Q1(<40.56) | 52.971 | |||||
| Q2(40.56~61.40) | 0.425 | 0.120 | 12.668 | 1.530 | (1.211,1.934) | <0.001 | |
| Q3(61.41~94.07) | 0.555 | 0.122 | 20.718 | 1.742 | (1.372,2.212) | <0.001 | |
| Q4(>94.07) | 0.919 | 0.131 | 49.523 | 2.507 | (1.941,3.239) | <0.001 | |
| CMI | Q1(<0.60) | 68.556 | |||||
| Q2(0.60~0.94) | 0.372 | 0.118 | 10.018 | 1.451 | (1.152,1.827) | 0.002 | |
| Q3(0.95~1.48) | 0.706 | 0.124 | 32.481 | 2.027 | (1.590,2.584) | <0.001 | |
| Q4(>1.48) | 1.012 | 0.132 | 58.902 | 2.750 | (2.124,3.561) | <0.001 | |
| CVAI | Q1(<109.82) | 275.337 | |||||
| Q2(109.82~137.85) | 1.020 | 0.116 | 76.797 | 2.773 | (2.208,3.484) | <0.001 | |
| Q3(137.86~167.21) | 1.587 | 0.130 | 148.872 | 4.890 | (3.789,6.310) | <0.001 | |
| Q4(>167.21) | 2.135 | 0.151 | 199.595 | 8.455 | (6.288,11.369) | <0.001 |
Table 2 Univariate Logistic analysis of the association between quartiles of five metabolic indexes and OSA
| 变量 | 区间 | B | SE | Wald χ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|---|
| AIP | Q1(<0.01) | 50.356 | |||||
| Q2(0.01~0.20) | 0.337 | 0.119 | 8.071 | 1.401 | (1.110,1.767) | 0.004 | |
| Q3(0.21~0.39) | 0.639 | 0.124 | 26.469 | 1.896 | (1.486,2.418) | <0.001 | |
| Q4(>0.39) | 0.838 | 0.129 | 42.075 | 2.311 | (1.794,2.976) | <0.001 | |
| VAI | Q1(<1.64) | 63.619 | |||||
| Q2(1.64~2.49) | 0.432 | 0.118 | 13.281 | 1.540 | (1.221,1.942) | <0.001 | |
| Q3(2.50~3.86) | 0.713 | 0.124 | 33.100 | 2.040 | (1.600,2.600) | <0.001 | |
| Q4(>3.86) | 0.954 | 0.130 | 53.855 | 2.595 | (2.012,3.348) | <0.001 | |
| LAP | Q1(<40.56) | 52.971 | |||||
| Q2(40.56~61.40) | 0.425 | 0.120 | 12.668 | 1.530 | (1.211,1.934) | <0.001 | |
| Q3(61.41~94.07) | 0.555 | 0.122 | 20.718 | 1.742 | (1.372,2.212) | <0.001 | |
| Q4(>94.07) | 0.919 | 0.131 | 49.523 | 2.507 | (1.941,3.239) | <0.001 | |
| CMI | Q1(<0.60) | 68.556 | |||||
| Q2(0.60~0.94) | 0.372 | 0.118 | 10.018 | 1.451 | (1.152,1.827) | 0.002 | |
| Q3(0.95~1.48) | 0.706 | 0.124 | 32.481 | 2.027 | (1.590,2.584) | <0.001 | |
| Q4(>1.48) | 1.012 | 0.132 | 58.902 | 2.750 | (2.124,3.561) | <0.001 | |
| CVAI | Q1(<109.82) | 275.337 | |||||
| Q2(109.82~137.85) | 1.020 | 0.116 | 76.797 | 2.773 | (2.208,3.484) | <0.001 | |
| Q3(137.86~167.21) | 1.587 | 0.130 | 148.872 | 4.890 | (3.789,6.310) | <0.001 | |
| Q4(>167.21) | 2.135 | 0.151 | 199.595 | 8.455 | (6.288,11.369) | <0.001 |
| 变量 | 区间 | B | SE | Waldχ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|---|
| AIP | Q1(<0.01) | 36.963 | |||||
| Q2(0.01~0.20) | 0.358 | 0.127 | 7.960 | 1.430 | (1.115,1.833) | 0.005 | |
| Q3(0.21~0.39) | 0.627 | 0.134 | 21.831 | 1.871 | (1.439,2.434) | <0.001 | |
| Q4(>0.39) | 0.807 | 0.144 | 31.330 | 2.241 | (1.689,2.972) | <0.001 | |
| VAI | Q1(<1.64) | 51.455 | |||||
| Q2(1.64~2.49) | 0.431 | 0.125 | 11.920 | 1.539 | (1.205,1.966) | 0.001 | |
| Q3(2.50~3.86) | 0.689 | 0.131 | 27.596 | 1.991 | (1.540,2.574) | <0.001 | |
| Q4(>3.86) | 0.923 | 0.138 | 44.520 | 2.517 | (1.919,3.301) | <0.001 | |
| LAP | Q1(<40.56) | 38.276 | |||||
| Q2(40.56~61.40) | 0.391 | 0.126 | 9.707 | 1.479 | (1.156,1.891) | 0.002 | |
| Q3(61.41~94.07) | 0.505 | 0.129 | 15.284 | 1.658 | (1.287,2.136) | <0.001 | |
| Q4(>94.07) | 0.839 | 0.139 | 36.344 | 2.313 | (1.761,3.038) | <0.001 | |
| CMI | Q1(<0.60) | 54.294 | |||||
| Q2(0.60~0.94) | 0.388 | 0.125 | 9.620 | 1.474 | (1.154,1.885) | 0.002 | |
| Q3(0.95~1.48) | 0.702 | 0.133 | 27.786 | 2.018 | (1.554,2.620) | <0.001 | |
| Q4(>1.48) | 1.005 | 0.145 | 47.721 | 2.732 | (2.054,3.633) | <0.001 | |
| CVAI | Q1(<109.82) | 157.831 | |||||
| Q2(109.82~137.85) | 0.807 | 0.122 | 44.017 | 2.242 | (1.766,2.846) | <0.001 | |
| Q3(137.86~167.21) | 1.304 | 0.138 | 89.050 | 3.683 | (2.810,4.829) | <0.001 | |
| Q4(>167.21) | 1.802 | 0.162 | 123.676 | 6.060 | (4.411,8.324) | <0.001 |
Table 3 Multivariate Logistic analysis of the association between quartiles of 5 metabolic indexes and OSA
| 变量 | 区间 | B | SE | Waldχ2值 | OR值 | 95%CI | P值 |
|---|---|---|---|---|---|---|---|
| AIP | Q1(<0.01) | 36.963 | |||||
| Q2(0.01~0.20) | 0.358 | 0.127 | 7.960 | 1.430 | (1.115,1.833) | 0.005 | |
| Q3(0.21~0.39) | 0.627 | 0.134 | 21.831 | 1.871 | (1.439,2.434) | <0.001 | |
| Q4(>0.39) | 0.807 | 0.144 | 31.330 | 2.241 | (1.689,2.972) | <0.001 | |
| VAI | Q1(<1.64) | 51.455 | |||||
| Q2(1.64~2.49) | 0.431 | 0.125 | 11.920 | 1.539 | (1.205,1.966) | 0.001 | |
| Q3(2.50~3.86) | 0.689 | 0.131 | 27.596 | 1.991 | (1.540,2.574) | <0.001 | |
| Q4(>3.86) | 0.923 | 0.138 | 44.520 | 2.517 | (1.919,3.301) | <0.001 | |
| LAP | Q1(<40.56) | 38.276 | |||||
| Q2(40.56~61.40) | 0.391 | 0.126 | 9.707 | 1.479 | (1.156,1.891) | 0.002 | |
| Q3(61.41~94.07) | 0.505 | 0.129 | 15.284 | 1.658 | (1.287,2.136) | <0.001 | |
| Q4(>94.07) | 0.839 | 0.139 | 36.344 | 2.313 | (1.761,3.038) | <0.001 | |
| CMI | Q1(<0.60) | 54.294 | |||||
| Q2(0.60~0.94) | 0.388 | 0.125 | 9.620 | 1.474 | (1.154,1.885) | 0.002 | |
| Q3(0.95~1.48) | 0.702 | 0.133 | 27.786 | 2.018 | (1.554,2.620) | <0.001 | |
| Q4(>1.48) | 1.005 | 0.145 | 47.721 | 2.732 | (2.054,3.633) | <0.001 | |
| CVAI | Q1(<109.82) | 157.831 | |||||
| Q2(109.82~137.85) | 0.807 | 0.122 | 44.017 | 2.242 | (1.766,2.846) | <0.001 | |
| Q3(137.86~167.21) | 1.304 | 0.138 | 89.050 | 3.683 | (2.810,4.829) | <0.001 | |
| Q4(>167.21) | 1.802 | 0.162 | 123.676 | 6.060 | (4.411,8.324) | <0.001 |
| 预测变量 | AUC | 95%CI | 截断值 | 灵敏度(%) | 特异度(%) | 约登指数 |
|---|---|---|---|---|---|---|
| TC | 0.530 | (0.505,0.555) | 5.265 | 20.5 | 84.9 | 0.054 |
| TG | 0.615 | (0.590,0.640) | 1.425 | 67.7 | 50.8 | 0.186 |
| HDL-C | 0.562 | (0.537,0.588) | 1.175 | 66.8 | 43.1 | 0.099 |
| LDL-C | 0.518 | (0.493,0.544) | 1.955 | 81.4 | 23.7 | 0.051 |
| AIP | 0.593 | (0.568,0.618) | 0.152 | 60.4 | 54.6 | 0.150 |
| VAI | 0.607 | (0.583,0.632) | 2.365 | 57.3 | 58.8 | 0.160 |
| LAP | 0.594 | (0.569,0.619) | 46.030 | 70.9 | 43.1 | 0.140 |
| CMI | 0.616 | (0.591,0.640) | 0.825 | 61.5 | 57.1 | 0.186 |
| CVAI | 0.728 | (0.706,0.751) | 125.265 | 70.8 | 65.4 | 0.362 |
Table 4 Receiver operating characteristic curve of lipid parameters and metabolic indexes in predicting OSA
| 预测变量 | AUC | 95%CI | 截断值 | 灵敏度(%) | 特异度(%) | 约登指数 |
|---|---|---|---|---|---|---|
| TC | 0.530 | (0.505,0.555) | 5.265 | 20.5 | 84.9 | 0.054 |
| TG | 0.615 | (0.590,0.640) | 1.425 | 67.7 | 50.8 | 0.186 |
| HDL-C | 0.562 | (0.537,0.588) | 1.175 | 66.8 | 43.1 | 0.099 |
| LDL-C | 0.518 | (0.493,0.544) | 1.955 | 81.4 | 23.7 | 0.051 |
| AIP | 0.593 | (0.568,0.618) | 0.152 | 60.4 | 54.6 | 0.150 |
| VAI | 0.607 | (0.583,0.632) | 2.365 | 57.3 | 58.8 | 0.160 |
| LAP | 0.594 | (0.569,0.619) | 46.030 | 70.9 | 43.1 | 0.140 |
| CMI | 0.616 | (0.591,0.640) | 0.825 | 61.5 | 57.1 | 0.186 |
| CVAI | 0.728 | (0.706,0.751) | 125.265 | 70.8 | 65.4 | 0.362 |
| [1] |
|
| [2] |
中华医学会呼吸分会睡眠呼吸障碍学组,中国医学装备协会呼吸病学装备技术专业委员会睡眠呼吸设备学组. 成人阻塞性睡眠呼吸暂停高危人群筛查与管理专家共识[J]. 中华健康管理学杂志,2022,16(8):520-528. DOI:10.3760/cma.j.cn115624-20220615-00460.
|
| [3] |
王云,何燕,刘师节,等. 阻塞性睡眠呼吸暂停低通气综合征与糖脂代谢紊乱的机制研究进展[J]. 中国全科医学,2022,25(2):243-247. DOI:10.12114/j.issn.1007-9572.2021.01.311.
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
于悦,谭慧文,刘奕姝,等. 阻塞性睡眠呼吸暂停低通气综合征病情严重程度的影响因素及代谢相关激素与临床相关指标的关系研究[J]. 中国全科医学,2021,24(8):947-953. DOI:10.12114/j.issn.1007-9572.2021.00.142.
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [1] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| [2] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [3] | XU Ping, MA Yan, HUANG Li, HE Meiliang, HOU Yunfeng, WANG Dewang, SUN Panpan, LIU Zheng, GUO Yanfang, XU Ying. Association between Weight-adjusted Waist Index and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Community-dwelling Adults [J]. Chinese General Practice, 2026, 29(16): 2198-2204. |
| [4] | ZHANG Qiuyu, HU Xiaoyong, TANG Rui, LI Hongjian. Correlation between Chinese Visceral Adiposity Index and Nocturnal Hypertension in Young and Middle-aged People [J]. Chinese General Practice, 2026, 29(07): 872-878. |
| [5] | HAN Zheng, FU Fanglin, SUN Meng, PAN Yaojia, WANG Weiqiang. A Cross-sectional Study on the Relationship between the Chinese Visceral Adiposity Index and Cardiometabolic Multimorbidity in Individuals Aged 60 and Above [J]. Chinese General Practice, 2026, 29(06): 693-698. |
| [6] | ZHANG Yanjing, ZHOU Chunhua, LI Xiaodong, LIU Yan, WANG Jing, YU Jing. Study on the Clinical Value of a Risk Prediction Model for Venlafaxine Plasma Concentration Exceeding the Safety Threshold [J]. Chinese General Practice, 2026, 29(06): 777-782. |
| [7] | LI Jie, YANG Xinhui, CAO Li, ZHANG Jing, JIANG Yue. Case Analysis of General Practice Diagnosis and Treatment in a "Three High" Patient with Coexistence and Fatty Liver Disease [J]. Chinese General Practice, 2026, 29(06): 810-816. |
| [8] | ZHANG Zhiwei, HE Panpan, YANG Qianwen, JIN Xueyi, MAO Xueqian, HU Ying, JING Lipeng. The Relationship between Different Obesity Indicators and Frailty among the Elderly in Rural Regions [J]. Chinese General Practice, 2026, 29(06): 699-709. |
| [9] | LI Shunan, ZHANG Shiyan, DENG Yanan, HU Danqing, ZHENG Yuxin, LI Danyang, LI Candong. An Analysis of Trends and Prediction of Disease Burden for Type 2 Diabetic Nephropathy from 1990 to 2021 in China [J]. Chinese General Practice, 2025, 28(33): 4214-4226. |
| [10] | LIU Chunyan, DENG Zhaohui, SONG Yingbo, YANG Fang, SHI Qian, LI Yongxin, ZHANG Xin. Comparison of Prevalence and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Xinjiang Residents [J]. Chinese General Practice, 2025, 28(32): 4031-4037. |
| [11] | ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali. Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(29): 3653-3659. |
| [12] | YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263. |
| [13] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
| [14] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
| [15] | HUANG Zhijie, MAI Zhihua, WANG Haoxiang, HE Yuming, DENG Qiaoyan, DAI Ranran, ZHOU Zhiheng. Multimorbidity of Hypertension, Diabetes, and Dyslipidemia and Influencing Factors of Family Function among the Elderly [J]. Chinese General Practice, 2025, 28(16): 2001-2010. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||